Raymond W. Cohen
Net Worth
Last updated:
What is Raymond W. Cohen net worth?
The estimated net worth of Mr. Raymond W. Cohen is at least $41,325,170 as of 31 Jan 2024. He has earned $35,145,170 from insider trading and has received compensation worth at least $6,180,000 in Axonics, Inc..
What is the salary of Raymond W. Cohen?
Mr. Raymond W. Cohen salary is $1,030,000 per year as Chief Executive Officer & Director in Axonics, Inc..
How old is Raymond W. Cohen?
Mr. Raymond W. Cohen is 66 years old, born in 1959.
What stocks does Raymond W. Cohen currently own?
As insider, Mr. Raymond W. Cohen owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Axonics, Inc. (AXNX) | Chief Executive Officer & Director | 188,835 | $0 | $0 |
What does Axonics, Inc. do?
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Raymond W. Cohen insider trading
Axonics, Inc.
Mr. Raymond W. Cohen has made 37 insider trades between 2019-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 96,846 units of AXNX stock on 3 Feb 2022. As of 31 Jan 2024 he still owns at least 188,835 units of AXNX stock.
Axonics key executives
Axonics, Inc. executives and other stock owners filed with the SEC:
- Dr. Karen L. Noblett M.D., M.A.S. (62) Chief Medical Officer
- Mr. Alfred J. Ford Jr. (54) Chief Commercial Officer
- Mr. Danny L. Dearen (62) Pres & Chief Financial Officer
- Mr. Raymond W. Cohen (66) Chief Executive Officer & Director
- Mr. Rinda K. Sama (46) Chief Operating Officer